RedHill Biopharma’s $39 Million Underwritten Public Offering

Gornitzky represented the underwriters, led by Roth Capital Partners, in RedHill Biopharma’s USD 39 million underwritten public offering of American Depositary Shares (ADSs) and warrants on…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Michael Patrini.

This content is for Standard 1 Year members only.
Login Join Now